Literature DB >> 8253799

Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells.

I M Adham1, E Burkhardt, M Benahmed, W Engel.   

Abstract

We have isolated complementary DNA clones coding for a novel member of the insulin-like hormone super-family from a boar testis cDNA library. Northern blot analysis and in situ hybridization revealed that the gene is expressed exclusively in prenatal and postnatal Leydig cells. We have tentatively proposed the name Leydig insulin-like (Ley I-L) for the gene and its encoded protein. The Leydig insulin-like protein is synthesized as a 131-amino acid preproprotein, which contains a 24-amino acid signal peptide. Comparison of the deduced amino acid sequence of pro-Leydig insulin-like protein with members of the insulin-like hormone superfamily predicts that the biologically active protein, after proteolytic processing of the C-peptide, consists of a 32-residue-long B-chain and a 26-residue-long A-chain and has a molecular size of 6.25 kDa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253799

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  New Insights into biological roles of relaxin and relaxin-related peptides.

Authors:  Jae-Il Park; Chia Lin Chang; Sheau Yu Teddy Hsu
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

2.  C-peptide of preproinsulin-like peptide 7: localization in the rat brain and activity in vitro.

Authors:  E Brailoiu; S L Dun; X Gao; G C Brailoiu; J-G Li; J J Luo; J Yang; J K Chang; L-Y Liu-Chen; N J Dun
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

3.  Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Authors:  Sabine Hombach-Klonisch; Joanna Bialek; Bogusz Trojanowicz; Ekkehard Weber; Hans-Jürgen Holzhausen; Josh D Silvertown; Alastair J Summerlee; Henning Dralle; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 4.  Relaxin family peptides: structure-activity relationship studies.

Authors:  Nitin A Patil; K Johan Rosengren; Frances Separovic; John D Wade; Ross A D Bathgate; Mohammed Akhter Hossain
Journal:  Br J Pharmacol       Date:  2017-01-19       Impact factor: 8.739

5.  Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment.

Authors:  Marco Rossato; Francesca Dassie; Valentina Silvestrin; Chiara Martini; Roberto Vettor; Pietro Maffei
Journal:  Endocrine       Date:  2014-06-12       Impact factor: 3.633

Review 6.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

7.  The small heat shock protein ODF1/HSPB10 is essential for tight linkage of sperm head to tail and male fertility in mice.

Authors:  Kefei Yang; Andreas Meinhardt; Bing Zhang; Pawel Grzmil; Ibrahim M Adham; Sigrid Hoyer-Fender
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

8.  A human cDNA coding for the Leydig insulin-like peptide (Ley I-L).

Authors:  E Burkhardt; I M Adham; U Hobohm; D Murphy; C Sander; W Engel
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

Review 9.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

10.  Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5).

Authors:  Mohammed Akhter Hossain; Ross A D Bathgate; Chze K Kong; Fazel Shabanpoor; Suode Zhang; Linda M Haugaard-Jönsson; K Johan Rosengren; Geoffrey W Tregear; John D Wade
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.